We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
-13.89%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
–
AUM
$4.5B
AUM Growth
-$744M
Cap. Flow
+$158M
Cap. Flow %
3.51%
Top 10 Hldgs %
18.83%
Holding
605
New
48
Increased
192
Reduced
136
Closed
31

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$39.6M
2
HES
Hess
HES
+$34.3M
3
PFE icon
Pfizer
PFE
+$14.5M
4
XYZ
Block Inc
XYZ
+$12.3M
5
KO icon
Coca-Cola
KO
+$12.2M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$31.4M
2
HMHC
Houghton Mifflin Harcourt Company
HMHC
+$19.3M
3
VMW
VMware, Inc
VMW
+$15.1M
4
CTRA
Coterra Energy
CTRA
+$15.1M
5
CSCO icon
Cisco
CSCO
+$12.3M

Sector Composition

Rank Sector Weight
1 Technology 29.9%
2 Healthcare 19.98%
3 Consumer Discretionary 10.77%
4 Financials 9.62%
5 Industrials 7.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KYMR icon
501
Kymera Therapeutics
KYMR
$8.51B
$223K 0.01%
11,000
– –
RCKT icon
502
Rocket Pharmaceuticals
RCKT
$340M
$218K ﹤0.01%
16,700
– –
BVN icon
503
Compañía de Minas Buenaventura
BVN
$7.69B
$210K ﹤0.01%
+31,000
New +$268K
REPL icon
504
Replimune Group
REPL
$941M
$208K ﹤0.01%
11,900
– –
IMGN
505
DELISTED
Immunogen Inc
IMGN
$205K ﹤0.01%
47,000
– –
CDW icon
506
CDW
CDW
$18.9B
$205K ﹤0.01%
1,300
-275
-17% -$46.2K
KURA icon
507
Kura Oncology
KURA
$800M
$200K ﹤0.01%
11,000
– –
ALEC icon
508
Alector
ALEC
$168M
$194K ﹤0.01%
19,000
– –
NKTR icon
509
Nektar Therapeutics
NKTR
$2.39B
$185K ﹤0.01%
3,120
– –
EDIT icon
510
Editas Medicine
EDIT
$396M
$183K ﹤0.01%
15,000
– –
MORF
511
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$180K ﹤0.01%
8,500
– –
AVXL icon
512
Anavex Life Sciences
AVXL
$255M
$178K ﹤0.01%
18,000
– –
VERV
513
DELISTED
Verve Therapeutics
VERV
$175K ﹤0.01%
11,300
– –
CNXT icon
514
VanEck ChiNext Innovators ETF
CNXT
$105M
$173K ﹤0.01%
4,400
– –
CDXS icon
515
Codexis
CDXS
$151M
$172K ﹤0.01%
15,500
– –
SU icon
516
Suncor Energy
SU
$79.4B
$168K ﹤0.01%
4,800
– –
ATRA icon
517
Atara Biotherapeutics
ATRA
$75.5M
$167K ﹤0.01%
880
– –
PVH icon
518
PVH
PVH
$4B
$158K ﹤0.01%
2,710
-90
-3% -$6.22K
SGMO
519
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$157K ﹤0.01%
38,000
– –
CLF icon
520
Cleveland-Cliffs
CLF
$6.57B
$157K ﹤0.01%
+10,000
New +$239K
RNAM
521
DELISTED
Avidity Biosciences
RNAM
$156K ﹤0.01%
10,900
– –
ROK icon
522
Rockwell Automation
ROK
$53.4B
$156K ﹤0.01%
782
-1,710
-69% -$386K
KROS icon
523
Keros Therapeutics
KROS
$199M
$155K ﹤0.01%
5,700
– –
RDUS
524
DELISTED
Radius Health, Inc.
RDUS
$154K ﹤0.01%
15,000
– –
ADAP
525
DELISTED
Adaptimmune Therapeutics
ADAP
$154K ﹤0.01%
90,000
– –
19 20
21
22 23

Similar funds

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
AAMU
APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $13B AUM 17.65% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return

Erste Asset Management's Q2 2022 Portfolio in Review

As of Q2 2022, Erste Asset Management held 605 positions worth $4.5B, down 14% from $5.24B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Erste Asset Management deployed $158M of net new capital in Q2 2022, opening 48 new positions and adding to 192 existing holdings. Its largest new stake was East-West Bancorp: 145,208 shares worth $9.42M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $31.4M trimmed.

  • Erste Asset Management's largest Q2 2022 buy was East-West Bancorp: 145,208 shares worth $9.42M.
  • Erste Asset Management added most to Netflix in Q2 2022, an estimated $39.6M increase.
  • Erste Asset Management's biggest Q2 2022 reduction was Bristol-Myers Squibb, cutting an estimated $31.4M.
  • Erste Asset Management fully exited Houghton Mifflin Harcourt Company in Q2 2022, selling an estimated $19.3M.
  • Erste Asset Management's ten largest holdings make up 19% of its $4.5B portfolio in Q2 2022.
  • Erste Asset Management opened 48 new positions and closed 31 in Q2 2022.
  • Erste Asset Management's portfolio value fell 14% quarter-over-quarter to $4.5B.

Based on Erste Asset Management's 13F filing for Q2 2022, filed 26 Nov 2024.